Carbapenem-Resistant but Cephalosporin-Susceptible <i>Pseudomonas aeruginosa</i> in Urinary Tract Infections: Opportunity for Colistin Sparing

This paper briefly reports the occurrence and epidemiology of carbapenem-resistant but cephalosporin-susceptible (Car-R/Ceph-S) <i>Pseudomonas aeruginosa</i> isolates from urinary tract infections (UTIs) in a tertiary-care hospital in the Southern Region of Hungary, and the phenotypic ch...

Full description

Bibliographic Details
Main Author: Márió Gajdács
Format: Article
Language:English
Published: MDPI AG 2020-04-01
Series:Antibiotics
Subjects:
Online Access:https://www.mdpi.com/2079-6382/9/4/153
_version_ 1827719533879623680
author Márió Gajdács
author_facet Márió Gajdács
author_sort Márió Gajdács
collection DOAJ
description This paper briefly reports the occurrence and epidemiology of carbapenem-resistant but cephalosporin-susceptible (Car-R/Ceph-S) <i>Pseudomonas aeruginosa</i> isolates from urinary tract infections (UTIs) in a tertiary-care hospital in the Southern Region of Hungary, and the phenotypic characterization of the possible resistance mechanisms in these isolates. Isolates and data were collected regarding <i>P. aeruginosa</i> UTIs corresponding to the period between 2008 and 2017. Susceptibility testing was performed using the Kirby–Bauer disk diffusion method; minimum inhibitory concentrations (MICs) of the isolates were determined using E-tests. The phenotypic detection of ampicillin C-type (AmpC) β-lactamases, efflux pump overexpression and carbapenemase production was also performed. <i>P. aeruginosa</i> represented <i>n</i> = 575 (2.72% ± 0.64%) from outpatient, and <i>n</i> = 1045 (5.43% ± 0.81%) from inpatient urinary samples, respectively. Based on the disk diffusion test, <i>n</i> = 359 (22.16%) were carbapenem-resistant; in addition to carbapenems, <i>n</i> = (64.34%) were also resistant to ciprofloxacin; <i>n</i> = (60.17%) to gentamicin/tobramycin; <i>n</i> = (58.51%) to levofloxacin; and <i>n</i> = (27.57%) to amikacin. From among the carbapenem-resistant isolates, <i>n</i> = 56 (15.59%) isolates were multidrug-resistant, while <i>n</i> = 16 (4.46%) were extensively drug-resistant. From among the Car-R/Ceph-S isolates (<i>n</i> = 57), overexpression of AmpC was observed in <i>n</i> = 7 cases (12.28%); carbapenemase production in <i>n</i> = 4 (7.02%); while overexpression of efflux pumps was present in <i>n</i> = 31 (54.39%) isolates. To spare last-resort agents, e.g., colistin, the use of broad-spectrum cephalosporins or safe, alternative agents should be considered in these infections.
first_indexed 2024-03-10T20:45:30Z
format Article
id doaj.art-fab9487c1127487ba6a8557bc15ffde4
institution Directory Open Access Journal
issn 2079-6382
language English
last_indexed 2024-03-10T20:45:30Z
publishDate 2020-04-01
publisher MDPI AG
record_format Article
series Antibiotics
spelling doaj.art-fab9487c1127487ba6a8557bc15ffde42023-11-19T20:22:50ZengMDPI AGAntibiotics2079-63822020-04-019415310.3390/antibiotics9040153Carbapenem-Resistant but Cephalosporin-Susceptible <i>Pseudomonas aeruginosa</i> in Urinary Tract Infections: Opportunity for Colistin SparingMárió Gajdács0Department of Pharmacodynamics and Biopharmacy, Faculty of Pharmacy, University of Szeged, 6720 Szeged, HungaryThis paper briefly reports the occurrence and epidemiology of carbapenem-resistant but cephalosporin-susceptible (Car-R/Ceph-S) <i>Pseudomonas aeruginosa</i> isolates from urinary tract infections (UTIs) in a tertiary-care hospital in the Southern Region of Hungary, and the phenotypic characterization of the possible resistance mechanisms in these isolates. Isolates and data were collected regarding <i>P. aeruginosa</i> UTIs corresponding to the period between 2008 and 2017. Susceptibility testing was performed using the Kirby–Bauer disk diffusion method; minimum inhibitory concentrations (MICs) of the isolates were determined using E-tests. The phenotypic detection of ampicillin C-type (AmpC) β-lactamases, efflux pump overexpression and carbapenemase production was also performed. <i>P. aeruginosa</i> represented <i>n</i> = 575 (2.72% ± 0.64%) from outpatient, and <i>n</i> = 1045 (5.43% ± 0.81%) from inpatient urinary samples, respectively. Based on the disk diffusion test, <i>n</i> = 359 (22.16%) were carbapenem-resistant; in addition to carbapenems, <i>n</i> = (64.34%) were also resistant to ciprofloxacin; <i>n</i> = (60.17%) to gentamicin/tobramycin; <i>n</i> = (58.51%) to levofloxacin; and <i>n</i> = (27.57%) to amikacin. From among the carbapenem-resistant isolates, <i>n</i> = 56 (15.59%) isolates were multidrug-resistant, while <i>n</i> = 16 (4.46%) were extensively drug-resistant. From among the Car-R/Ceph-S isolates (<i>n</i> = 57), overexpression of AmpC was observed in <i>n</i> = 7 cases (12.28%); carbapenemase production in <i>n</i> = 4 (7.02%); while overexpression of efflux pumps was present in <i>n</i> = 31 (54.39%) isolates. To spare last-resort agents, e.g., colistin, the use of broad-spectrum cephalosporins or safe, alternative agents should be considered in these infections.https://www.mdpi.com/2079-6382/9/4/153<i>Pseudomonas aeruginosa</i>urinary tract infectioncarbapenemcephalosporinresistanceuncommon phenotype
spellingShingle Márió Gajdács
Carbapenem-Resistant but Cephalosporin-Susceptible <i>Pseudomonas aeruginosa</i> in Urinary Tract Infections: Opportunity for Colistin Sparing
Antibiotics
<i>Pseudomonas aeruginosa</i>
urinary tract infection
carbapenem
cephalosporin
resistance
uncommon phenotype
title Carbapenem-Resistant but Cephalosporin-Susceptible <i>Pseudomonas aeruginosa</i> in Urinary Tract Infections: Opportunity for Colistin Sparing
title_full Carbapenem-Resistant but Cephalosporin-Susceptible <i>Pseudomonas aeruginosa</i> in Urinary Tract Infections: Opportunity for Colistin Sparing
title_fullStr Carbapenem-Resistant but Cephalosporin-Susceptible <i>Pseudomonas aeruginosa</i> in Urinary Tract Infections: Opportunity for Colistin Sparing
title_full_unstemmed Carbapenem-Resistant but Cephalosporin-Susceptible <i>Pseudomonas aeruginosa</i> in Urinary Tract Infections: Opportunity for Colistin Sparing
title_short Carbapenem-Resistant but Cephalosporin-Susceptible <i>Pseudomonas aeruginosa</i> in Urinary Tract Infections: Opportunity for Colistin Sparing
title_sort carbapenem resistant but cephalosporin susceptible i pseudomonas aeruginosa i in urinary tract infections opportunity for colistin sparing
topic <i>Pseudomonas aeruginosa</i>
urinary tract infection
carbapenem
cephalosporin
resistance
uncommon phenotype
url https://www.mdpi.com/2079-6382/9/4/153
work_keys_str_mv AT mariogajdacs carbapenemresistantbutcephalosporinsusceptibleipseudomonasaeruginosaiinurinarytractinfectionsopportunityforcolistinsparing